These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31479592)

  • 41. Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.
    Vikingsson S; Gréen H; Brinkhagen L; Mukhtar S; Josefsson M
    Drug Test Anal; 2016 Sep; 8(9):950-6. PubMed ID: 26560240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of new legislation in Germany on prevalence and harm of synthetic cannabinoids.
    Sommer MJ; Halter S; Angerer V; Auwärter V; Eyer F; Liebetrau G; Ebbecke M; Hermanns-Clausen M
    Clin Toxicol (Phila); 2022 Oct; 60(10):1130-1138. PubMed ID: 36074033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Profiling of synthesis-related impurities of the synthetic cannabinoid Cumyl-5F-PINACA in seized samples of e-liquids via multivariate analysis of UHPLC-MS
    Münster-Müller S; Matzenbach I; Knepper T; Zimmermann R; Pütz M
    Drug Test Anal; 2020 Jan; 12(1):119-126. PubMed ID: 31307120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures.
    Kevin RC; Kovach AL; Lefever TW; Gamage TF; Wiley JL; McGregor IS; Thomas BF
    Forensic Toxicol; 2019 Jan; 37(1):17-26. PubMed ID: 30705707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
    Yeter O; Ozturk YE
    Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.
    Scheidweiler KB; Jarvis MJ; Huestis MA
    Anal Bioanal Chem; 2015 Jan; 407(3):883-97. PubMed ID: 25224637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201.
    McQuade D; Hudson S; Dargan PI; Wood DM
    Eur J Clin Pharmacol; 2013 Mar; 69(3):373-6. PubMed ID: 22936123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Freeze-thaw stability and long-term stability of 84 synthetic cannabinoids in serum.
    Hess C; Krueger L; Unger M; Madea B
    Drug Test Anal; 2017 Oct; 9(10):1506-1511. PubMed ID: 27863089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine.
    Kronstrand R; Brinkhagen L; Birath-Karlsson C; Roman M; Josefsson M
    Anal Bioanal Chem; 2014 Jun; 406(15):3599-609. PubMed ID: 24424965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid analysis of synthetic cannabinoids using a miniature mass spectrometer with ambient ionization capability.
    Ma Q; Bai H; Li W; Wang C; Cooks RG; Ouyang Z
    Talanta; 2015 Sep; 142():190-6. PubMed ID: 26003711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 1-Adamantylamine a simple urine marker for screening for third generation adamantyl-type synthetic cannabinoids by ultra-performance liquid chromatography tandem mass spectrometry.
    Ford LT; Berg JD
    Ann Clin Biochem; 2016 Nov; 53(6):640-646. PubMed ID: 26748105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enzyme-linked immunosorbent assay (ELISA) for the detection of use of the synthetic cannabinoid agonists UR-144 and XLR-11 in human urine.
    Mohr AL; Ofsa B; Keil AM; Simon JR; McMullin M; Logan BK
    J Anal Toxicol; 2014 Sep; 38(7):427-31. PubMed ID: 24908262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of synthetic cannabinoids in oral fluid using ELISA and LC-MS-MS.
    Rodrigues WC; Catbagan P; Rana S; Wang G; Moore C
    J Anal Toxicol; 2013 Oct; 37(8):526-33. PubMed ID: 23946452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural characterization of the new synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA.
    Bovens M; Bissig C; Staeheli SN; Poetzsch M; Pfeiffer B; Kraemer T
    Forensic Sci Int; 2017 Dec; 281():98-105. PubMed ID: 29125990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls.
    Möller I; Wintermeyer A; Bender K; Jübner M; Thomas A; Krug O; Schänzer W; Thevis M
    Drug Test Anal; 2011 Sep; 3(9):609-20. PubMed ID: 20872894
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LC/ESI-MS/MS method for quantification of 28 synthetic cannabinoids in neat oral fluid and its application to preliminary studies on their detection windows.
    Kneisel S; Speck M; Moosmann B; Corneillie TM; Butlin NG; Auwärter V
    Anal Bioanal Chem; 2013 May; 405(14):4691-706. PubMed ID: 23535743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques.
    Hutter M; Broecker S; Kneisel S; Auwärter V
    J Mass Spectrom; 2012 Jan; 47(1):54-65. PubMed ID: 22282090
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites.
    Diao X; Huestis MA
    Clin Pharmacol Ther; 2017 Feb; 101(2):239-253. PubMed ID: 27727455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of UR-144 and its pyrolysis product in blood and their metabolites in urine.
    Adamowicz P; Zuba D; Sekuła K
    Forensic Sci Int; 2013 Dec; 233(1-3):320-7. PubMed ID: 24314536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.